Nutra Pharma Corp NVIDIA Bond
NPHC Stock | USD 0.0001 0.00 0.00% |
Nutra Pharma's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Nutra Pharma's financial risk is the risk to Nutra Pharma stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Nutra |
Given the importance of Nutra Pharma's capital structure, the first step in the capital decision process is for the management of Nutra Pharma to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Nutra Pharma Corp to issue bonds at a reasonable cost.
Popular Name | Nutra Pharma NVIDIA PORATION |
Equity ISIN Code | US67060U2087 |
Bond Issue ISIN Code | US67066GAG91 |
Nutra Pharma Corp Outstanding Bond Obligations
Boeing Co 2196 | US097023DG73 | Details | |
NVIDIA PORATION | US67066GAN43 | Details | |
NVIDIA PORATION | US67066GAM69 | Details | |
US67066GAJ31 | US67066GAJ31 | Details | |
NVIDIA PORATION | US67066GAG91 | Details | |
NVIDIA PORATION | US67066GAH74 | Details | |
NVIDIA P 32 | US67066GAE44 | Details | |
NVIDIA PORATION | US67066GAF19 | Details | |
HSBC Holdings PLC | US404280DR76 | Details | |
MGM Resorts International | US552953CD18 | Details | |
AerCap Global Aviation | US00773HAA59 | Details |
Understaning Nutra Pharma Use of Financial Leverage
Nutra Pharma's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Nutra Pharma's total debt position, including all outstanding debt obligations, and compares it with Nutra Pharma's equity. Financial leverage can amplify the potential profits to Nutra Pharma's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Nutra Pharma is unable to cover its debt costs.
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people. Please read more on our technical analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nutra Pink Sheet
Nutra Pharma financial ratios help investors to determine whether Nutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nutra with respect to the benefits of owning Nutra Pharma security.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.